• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过非增强T1映射对安德森-法布里病左心室心肌病变进行逐段评估。

Segment-by-segment assessment of left ventricular myocardial affection in Anderson-Fabry disease by non-enhanced T1-mapping.

作者信息

Walter Thula C, Knobloch Gesine, Canaan-Kuehl Sima, Greiser Andreas, Sandek Anja, Blaschke Daniela, Denecke Timm, Hamm Bernd, Makowski Marcus R

机构信息

1 Department of Radiology, Charité, Germany.

2 Department of Nephrology, Charité, Germany.

出版信息

Acta Radiol. 2017 Aug;58(8):914-921. doi: 10.1177/0284185116675657. Epub 2016 Oct 31.

DOI:10.1177/0284185116675657
PMID:27799574
Abstract

Background Anderson-Fabry disease (AFD) is an X-linked lysosomal enzyme disorder associated with an intracellular accumulation of sphingolipids, which shorten myocardial T1 relaxation times. Myocardial affection, however, varies between different segments. Purpose To evaluate the specific segmental distribution and degree of segmental affection in AFD patients. Material and Methods Twenty-five patients with AFD, 14 patients with hypertrophic cardiomyopathy (HCM), and 21 controls were included. A Modified Look-Locker Inversion Recovery sequence (MOLLI) was used for non-enhanced T1 mapping at 1.5 T in addition to standard cardiac imaging in 10-12 short axis views. T1 values were evaluated with a mixed model ANOVA and regression analysis to determine the best diagnostic cutoff values for T1 for each myocardial segment. Results Regression analysis showed the best diagnostic cutoff compared to controls in cardiac segments 1-4, 8-9, and 14. Mean differences between T1 for AFD versus HCM were greatest in segment 3, 4, and 9 (99 ms, 103 ms, 86 ms, respectively). Overall T1 times were 888 ± 70 ms and 903 ± 14 ms (AFD with and without LVH); 1014 ± 17 ms and 1001 ± 22 ms (HCM and controls, P < 0.05). Conclusion Myocardial segments are affected by a varying degree of T1 shortening in AFD patients. Segment-specific cutoff values allow the most specific detection and quantification of the extent of myocardial affection.

摘要

背景

安德森-法布里病(AFD)是一种X连锁溶酶体酶紊乱疾病,与鞘脂在细胞内蓄积有关,鞘脂蓄积会缩短心肌T1弛豫时间。然而,心肌受累情况在不同节段有所不同。目的:评估AFD患者心肌节段的特定分布及节段受累程度。材料与方法:纳入25例AFD患者、14例肥厚型心肌病(HCM)患者和21例对照者。除了在10 - 12个短轴视图下进行标准心脏成像外,还使用改良的Look-Locker反转恢复序列(MOLLI)在1.5T下进行非增强T1映射。采用混合模型方差分析和回归分析评估T1值,以确定每个心肌节段T1的最佳诊断临界值。结果:回归分析显示,在心脏节段1 - 4、8 - 9和14中,与对照组相比有最佳诊断临界值。AFD与HCM的T1平均差异在节段3、4和9中最大(分别为99ms、103ms、86ms)。总体T1时间分别为888±70ms和903±14ms(有和无左心室肥厚的AFD患者);1014±17ms和1001±22ms(HCM患者和对照者,P < 0.05)。结论:AFD患者的心肌节段受到不同程度的T1缩短影响。节段特异性临界值能够最特异性地检测和量化心肌受累程度。

相似文献

1
Segment-by-segment assessment of left ventricular myocardial affection in Anderson-Fabry disease by non-enhanced T1-mapping.通过非增强T1映射对安德森-法布里病左心室心肌病变进行逐段评估。
Acta Radiol. 2017 Aug;58(8):914-921. doi: 10.1177/0284185116675657. Epub 2016 Oct 31.
2
Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy.使用 3.0T 心肌 T1 映射区分安德森-法布里病与肥厚型心肌病。
Radiology. 2018 Aug;288(2):398-406. doi: 10.1148/radiol.2018172613. Epub 2018 Apr 24.
3
Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.应用心血管磁共振对比增强心肌 T1 mapping 技术对安德森-法布里病进行识别和评估。
Circ Cardiovasc Imaging. 2013 May 1;6(3):392-8. doi: 10.1161/CIRCIMAGING.112.000070. Epub 2013 Apr 5.
4
Hybrid positron emission tomography-magnetic resonance imaging for assessing different stages of cardiac impairment in patients with Anderson-Fabry disease: AFFINITY study group.应用正电子发射断层扫描-磁共振成像技术评估安德森-法布里病患者不同阶段的心功能障碍:AFFINITY 研究组。
Eur Heart J Cardiovasc Imaging. 2019 Sep 1;20(9):1004-1011. doi: 10.1093/ehjci/jez039.
5
Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis.磁共振心脏 T1 mapping 在安德森-法布里病中的应用:系统评价和荟萃分析。
J Cardiovasc Magn Reson. 2022 May 23;24(1):31. doi: 10.1186/s12968-022-00859-z.
6
Reduced Right Ventricular Native Myocardial T1 in Anderson-Fabry Disease: Comparison to Pulmonary Hypertension and Healthy Controls.安德森-法布里病患者右心室心肌固有T1降低:与肺动脉高压及健康对照的比较
PLoS One. 2016 Jun 15;11(6):e0157565. doi: 10.1371/journal.pone.0157565. eCollection 2016.
7
Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping.应用心脏 T1 mapping 技术对法布里病与肥厚型心肌病进行鉴别诊断。
Diagn Interv Imaging. 2020 Feb;101(2):59-67. doi: 10.1016/j.diii.2019.08.006. Epub 2019 Sep 10.
8
Proposed Stages of Myocardial Phenotype Development in Fabry Disease.法布里病心肌表型发育的拟议阶段。
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1673-1683. doi: 10.1016/j.jcmg.2018.03.020. Epub 2018 May 16.
9
Native T reference values for nonischemic cardiomyopathies and populations with increased cardiovascular risk: A systematic review and meta-analysis.原发性 T 参考值在非缺血性心肌病和心血管风险增加人群中的应用:系统评价和荟萃分析。
J Magn Reson Imaging. 2018 Apr;47(4):891-912. doi: 10.1002/jmri.25885. Epub 2017 Nov 13.
10
Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.安德森-法布里心肌病:患病率、病理生理学、诊断与治疗
Heart Fail Rev. 2015 Mar;20(2):179-91. doi: 10.1007/s10741-014-9452-9.

引用本文的文献

1
Cardiac magnetic resonance imaging in Fabry disease.法布里病的心脏磁共振成像
J Clin Imaging Sci. 2025 Jun 25;15:23. doi: 10.25259/JCIS_155_2024. eCollection 2025.
2
Fabry Disease Cardiomyopathy: A Review of the Role of Cardiac Imaging from Diagnosis to Treatment.法布里病心肌病:从诊断到治疗的心脏成像作用综述
Rev Cardiovasc Med. 2022 May 27;23(6):192. doi: 10.31083/j.rcm2306192. eCollection 2022 Jun.
3
Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis.
磁共振心脏 T1 mapping 在安德森-法布里病中的应用:系统评价和荟萃分析。
J Cardiovasc Magn Reson. 2022 May 23;24(1):31. doi: 10.1186/s12968-022-00859-z.
4
Storage diseases with hypertrophic cardiomyopathy phenotype.具有肥厚型心肌病表型的贮积病。
Glob Cardiol Sci Pract. 2018 Aug 12;2018(3):28. doi: 10.21542/gcsp.2018.28.